Experts say antiviral therapeutics need to be an investment priority if another pandemic were to happen in the future, due to the possible length of time a vaccine takes to develop.
Chair of the Doherty Institute, Martyn Myer: Goodwill and ingenuity don’t pay the bills in the world of scientific research, Australia needs to tap in.